Ignite Creation Date:
2025-12-26 @ 5:22 PM
Ignite Modification Date:
2026-03-03 @ 8:08 AM
Study NCT ID:
NCT02511106
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-28
First Post:
2015-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2015-07-28
First Submit QC Date:
None
Study First Post Date:
2015-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-15
Results First Submit QC Date:
None
Results First Post Date:
2021-07-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-27
Last Update Post Date:
2025-08-28
Last Update Post Date Type:
ESTIMATED